WhiteOak Capital Pharma and Healthcare Fund Regular Growth is a Sector - Healthcare mutual fund scheme from WhiteOak Capital Asset Management Limited. The fund was launched on 6 February 2024 and is managed by Ramesh Mantri, Dheeresh Pathak, Trupti Agrawal, Ashish Agrawal, and Piyush Baranwal. As of 15 October 2026, the fund has an AUM of ₹926.55 Cr and its latest NAV is ₹15.91. The fund has a Very High Risk risk rating.
The fund allows minimum SIP of ₹100 and lumpsum investment starting from ₹500.
The fund primarily invests in Healthcare and Basic Materials and its top holdings include Divi's Laboratories Ltd, Sun Pharmaceuticals Industries Ltd, J.B. Chemicals & Pharmaceuticals Ltd, Torrent Pharmaceuticals Ltd, and Laurus Labs Ltd. The fund has delivered 14.4% returns over the last 1 year and 19.0% annualised returns since inception.
WhiteOak Capital Pharma and Healthcare Fund Regular Growth may be suitable for investors looking for Sector - Healthcare and who are comfortable with Very High Risk risk.






